SK287073B6 - N-Acyldipeptidový derivát, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents
N-Acyldipeptidový derivát, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje Download PDFInfo
- Publication number
- SK287073B6 SK287073B6 SK1887-2000A SK18872000A SK287073B6 SK 287073 B6 SK287073 B6 SK 287073B6 SK 18872000 A SK18872000 A SK 18872000A SK 287073 B6 SK287073 B6 SK 287073B6
- Authority
- SK
- Slovakia
- Prior art keywords
- cells
- antigen
- adjuvant
- solution
- minutes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9801396 | 1998-06-30 | ||
| PCT/IB1999/001170 WO2000000462A1 (fr) | 1998-06-30 | 1999-06-23 | Nouveaux pseudodipeptides acyles, leur mode de preparation et les compositions pharmaceutiques en renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK18872000A3 SK18872000A3 (sk) | 2001-07-10 |
| SK287073B6 true SK287073B6 (sk) | 2009-11-05 |
Family
ID=9522667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1887-2000A SK287073B6 (sk) | 1998-06-30 | 1999-06-23 | N-Acyldipeptidový derivát, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7157092B1 (zh) |
| EP (1) | EP1091928B1 (zh) |
| JP (1) | JP4699609B2 (zh) |
| KR (1) | KR100766016B1 (zh) |
| CN (1) | CN1168702C (zh) |
| AR (1) | AR029877A1 (zh) |
| AT (1) | ATE355266T1 (zh) |
| AU (1) | AU761396B2 (zh) |
| BR (1) | BR9911329A (zh) |
| CA (1) | CA2337807C (zh) |
| CZ (1) | CZ302062B6 (zh) |
| DE (1) | DE69935330T2 (zh) |
| DK (1) | DK1091928T3 (zh) |
| EE (1) | EE04489B1 (zh) |
| ES (1) | ES2284275T3 (zh) |
| HU (1) | HUP0102475A3 (zh) |
| PL (1) | PL195764B1 (zh) |
| RU (1) | RU2223262C2 (zh) |
| SK (1) | SK287073B6 (zh) |
| TW (1) | TWI255808B (zh) |
| WO (1) | WO2000000462A1 (zh) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69935330T2 (de) * | 1998-06-30 | 2007-10-31 | Om Pharma | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen |
| AU1581400A (en) * | 1999-12-22 | 2001-07-03 | Om Pharma | Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| CA2437358A1 (en) * | 2001-01-30 | 2002-08-22 | University Of Virginia Patent Foundation | Agonists and antagonists of sphingosine-1-phosphate receptors |
| JP4516748B2 (ja) | 2001-09-14 | 2010-08-04 | サイトス バイオテクノロジー アーゲー | ウィルス様粒子中への免疫賦活物質のパッケージ化：調製法および使用法 |
| AU2003250106B2 (en) | 2002-07-18 | 2009-11-26 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| WO2004084940A1 (en) | 2003-03-26 | 2004-10-07 | Cytos Biotechnology Ag | Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| ATE491467T1 (de) | 2004-05-28 | 2011-01-15 | Glaxosmithkline Biolog Sa | Impfstoffzusammensetzungen mit virosomen und einem saponin-adjuvans |
| GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| WO2006100111A1 (en) | 2005-03-23 | 2006-09-28 | Glaxosmithkline Biologicals S.A. | Composition |
| US20070184068A1 (en) | 2005-12-14 | 2007-08-09 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| EA014107B1 (ru) | 2005-12-22 | 2010-10-29 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| JP5341526B2 (ja) * | 2006-03-09 | 2013-11-13 | オーエム ファーマ | 免疫調節化合物、及び炎症性サイトカインの過剰産生に関連する疾患の治療 |
| US20100021503A1 (en) | 2006-03-30 | 2010-01-28 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| ES2738986T3 (es) | 2006-06-12 | 2020-01-28 | Kuros Biosciences Ag | Procesos para empaquetar oligonucleótidos en partículas de tipo viral de bacteriófagos de ARN |
| DK2422810T3 (da) | 2006-07-17 | 2014-11-24 | Glaxosmithkline Biolog Sa | Influenzavaccine |
| KR20090094213A (ko) | 2006-07-18 | 2009-09-04 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 말라리아 백신 |
| GB2453475B (en) | 2006-07-25 | 2011-01-19 | Secr Defence | Live vaccine strain |
| SI2086582T1 (sl) | 2006-10-12 | 2013-02-28 | Glaxosmithkline Biologicals S.A. | Cepivo, ki obsega emulzijo olja v vodi kot adjuvans |
| PL2137210T3 (pl) | 2007-03-02 | 2017-06-30 | Glaxosmithkline Biologicals Sa | Nowy sposób i kompozycje |
| US9452209B2 (en) | 2007-04-20 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
| PT2167121E (pt) | 2007-06-26 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae |
| EP2020240A1 (en) * | 2007-07-30 | 2009-02-04 | Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe | Methods and substances for the treatment of Alzheimer's |
| ES2626634T3 (es) | 2007-12-19 | 2017-07-25 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Formas solubles de la glucoproteína F del virus de Hendra y Nipah y usos de la misma |
| CA2710600C (en) | 2007-12-24 | 2017-06-06 | Id Biomedical Corporation Of Quebec | Recombinant rsv antigens |
| ES2553113T3 (es) | 2008-04-16 | 2015-12-04 | Glaxosmithkline Biologicals S.A. | Vacuna |
| JP2012510284A (ja) | 2008-12-03 | 2012-05-10 | プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ | ワクチンの開発のためのフェノール可溶性モジュリンの使用 |
| WO2010079081A1 (en) | 2009-01-07 | 2010-07-15 | Glaxosmithkline Biologicals S.A. | Methods for recovering a virus or a viral antigen produced by cell culture |
| GB0901423D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| GB0901411D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| JP5843615B2 (ja) | 2009-02-06 | 2016-01-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 密度勾配超遠心分離によるウイルスまたはウイルス抗原の精製 |
| MX338898B (es) | 2009-02-17 | 2016-05-03 | Glaxosmithkline Biolog Sa | Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio. |
| GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
| MA33449B1 (fr) | 2009-06-24 | 2012-07-03 | Glaxosmithkline Biolog Sa | Antigènes recombinants du vrs |
| JP5796011B2 (ja) | 2009-06-24 | 2015-10-21 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| EP3988115A3 (en) | 2009-07-15 | 2022-08-17 | GlaxoSmithKline Biologicals S.A. | Rsv f protein compositions and methods for making same |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US9341623B2 (en) | 2009-09-25 | 2016-05-17 | Glaxosmithkline Biologicals Sa | Immunodiffusion assay for influenza virus |
| GB0919117D0 (en) | 2009-10-30 | 2009-12-16 | Glaxosmithkline Biolog Sa | Process |
| WO2011101332A1 (en) | 2010-02-16 | 2011-08-25 | Proyecto De Biomedicina Cima, S.L. | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma |
| EP2566958B1 (en) | 2010-05-03 | 2015-12-30 | GlaxoSmithKline Biologicals S.A. | Method for inactivating influenza virus |
| GB201009273D0 (en) | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
| BR112013008624B1 (pt) | 2010-10-15 | 2022-07-26 | Glaxosmithkline Biologicals S.A. | Polipeptídeo gb de citomegalovírus (cmv), preparação, composição imunogênica, polinucleotídeo, vetor recombinante, e, microrganismo transgênico |
| EP2505640A1 (en) | 2011-03-29 | 2012-10-03 | Neo Virnatech, S.L. | Vaccine compositions for birnavirus-borne diseases |
| LT2707385T (lt) | 2011-05-13 | 2017-12-11 | Glaxosmithkline Biologicals Sa | Iš anksto sulieti rsv f antigenai |
| JP2014515035A (ja) | 2011-05-17 | 2014-06-26 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ストレプトコッカス・ニューモニエに対するワクチン |
| WO2013139744A1 (en) | 2012-03-18 | 2013-09-26 | Glaxosmithkline Biologicals S.A. | Method of vaccination against human papillomavirus |
| JP2015525794A (ja) | 2012-08-06 | 2015-09-07 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法 |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| EP3608332B1 (en) | 2013-03-15 | 2022-06-01 | GlaxoSmithKline Biologicals SA | Vaccine against human rhinovirus |
| WO2015011254A1 (en) | 2013-07-26 | 2015-01-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of bacterial infections |
| BR112016002354A2 (pt) | 2013-08-05 | 2017-09-12 | Glaxosmithkline Biologicals Sa | composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit |
| US10392603B2 (en) | 2013-08-30 | 2019-08-27 | The Chemo-Sero-Therapeutic Research Institute | Method of viral purification |
| CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
| US10821175B2 (en) | 2014-02-25 | 2020-11-03 | Merck Sharp & Dohme Corp. | Lipid nanoparticle vaccine adjuvants and antigen delivery systems |
| WO2015165480A1 (en) | 2014-04-30 | 2015-11-05 | Institute For Research In Biomedicine | Human cytomegalovirus vaccine compositions and method of producing the same |
| EP3154576A1 (en) | 2014-06-13 | 2017-04-19 | GlaxoSmithKline Biologicals S.A. | Immunogenic combinations |
| WO2016180852A1 (en) | 2015-05-12 | 2016-11-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for preparing antigen-specific t cells from an umbilical cord blood sample |
| EP3313435A1 (en) | 2015-06-26 | 2018-05-02 | Institute for Research in Biomedicine | Novel vaccines in prevention and treatment of malaria |
| GB201614799D0 (en) | 2016-09-01 | 2016-10-19 | Glaxosmithkline Biologicals Sa | Compositions |
| WO2018162450A1 (en) | 2017-03-06 | 2018-09-13 | Fundación Para La Investigación Médica Aplicada | New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells |
| EP3581201A1 (en) | 2018-06-15 | 2019-12-18 | GlaxoSmithKline Biologicals S.A. | Escherichia coli o157:h7 proteins and uses thereof |
| US11911553B2 (en) * | 2018-07-06 | 2024-02-27 | Fenwal, Inc. | Systems and methods for concentrating cells with a syringe and a centrifuge |
| US20230201334A1 (en) | 2019-07-24 | 2023-06-29 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN112329267B (zh) * | 2020-11-26 | 2022-08-16 | 中国核动力研究设计院 | 一种基于特征线法的组合几何中子输运处理方法及装置 |
| IL303334A (en) | 2020-12-02 | 2023-07-01 | Glaxosmithkline Biologicals Sa | Donor strand complemented fimh |
| WO2022161598A1 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
| WO2022162012A2 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
| WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61227586A (ja) * | 1985-03-30 | 1986-10-09 | Dai Ichi Seiyaku Co Ltd | ジサツカライド誘導体およびその塩 |
| US4746742A (en) * | 1985-11-28 | 1988-05-24 | Toho Yakuhin Kogyo Kabushiki Kaisha | Analogs of nonreducing monosaccharide moiety of lipid A |
| DE4229877C2 (de) * | 1992-09-04 | 1994-09-15 | Max Delbrueck Centrum | Phospho- bzw. Phosphono-(N-acyl)-serine und ihre Herstellung |
| EP0668289A4 (en) * | 1993-09-07 | 1998-10-21 | Suntory Ltd | NEW DISACCHARIDE DERIVATIVE. |
| WO1995014026A1 (en) * | 1993-11-17 | 1995-05-26 | Laboratoires Om S.A. | Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| DE69935330T2 (de) * | 1998-06-30 | 2007-10-31 | Om Pharma | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen |
-
1999
- 1999-06-23 DE DE69935330T patent/DE69935330T2/de not_active Expired - Lifetime
- 1999-06-23 AT AT99957636T patent/ATE355266T1/de not_active IP Right Cessation
- 1999-06-23 KR KR1020007015066A patent/KR100766016B1/ko not_active IP Right Cessation
- 1999-06-23 HU HU0102475A patent/HUP0102475A3/hu unknown
- 1999-06-23 CA CA2337807A patent/CA2337807C/fr not_active Expired - Fee Related
- 1999-06-23 AU AU42848/99A patent/AU761396B2/en not_active Ceased
- 1999-06-23 US US09/720,045 patent/US7157092B1/en not_active Expired - Fee Related
- 1999-06-23 ES ES99957636T patent/ES2284275T3/es not_active Expired - Lifetime
- 1999-06-23 RU RU2001102614/04A patent/RU2223262C2/ru not_active IP Right Cessation
- 1999-06-23 CN CNB998077615A patent/CN1168702C/zh not_active Expired - Fee Related
- 1999-06-23 BR BR9911329-5A patent/BR9911329A/pt not_active Application Discontinuation
- 1999-06-23 EE EEP200000791A patent/EE04489B1/xx not_active IP Right Cessation
- 1999-06-23 WO PCT/IB1999/001170 patent/WO2000000462A1/fr active IP Right Grant
- 1999-06-23 PL PL99345040A patent/PL195764B1/pl not_active IP Right Cessation
- 1999-06-23 EP EP99957636A patent/EP1091928B1/fr not_active Expired - Lifetime
- 1999-06-23 DK DK99957636T patent/DK1091928T3/da active
- 1999-06-23 SK SK1887-2000A patent/SK287073B6/sk not_active IP Right Cessation
- 1999-06-23 CZ CZ20004893A patent/CZ302062B6/cs not_active IP Right Cessation
- 1999-06-23 JP JP2000557223A patent/JP4699609B2/ja not_active Expired - Fee Related
- 1999-06-30 AR ARP990103172A patent/AR029877A1/es active IP Right Grant
- 1999-07-30 TW TW088112968A patent/TWI255808B/zh not_active IP Right Cessation
-
2006
- 2006-02-28 US US11/363,691 patent/US20060148678A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1091928B1 (fr) | 2007-02-28 |
| KR20010083078A (ko) | 2001-08-31 |
| CN1168702C (zh) | 2004-09-29 |
| HUP0102475A2 (hu) | 2001-11-28 |
| US20060148678A1 (en) | 2006-07-06 |
| ATE355266T1 (de) | 2006-03-15 |
| PL195764B1 (pl) | 2007-10-31 |
| AR029877A1 (es) | 2003-07-23 |
| CA2337807C (fr) | 2012-08-21 |
| AU761396B2 (en) | 2003-06-05 |
| TWI255808B (en) | 2006-06-01 |
| CN1306504A (zh) | 2001-08-01 |
| DE69935330T2 (de) | 2007-10-31 |
| DE69935330D1 (de) | 2007-04-12 |
| CA2337807A1 (fr) | 2000-01-06 |
| PL345040A1 (en) | 2001-11-19 |
| RU2223262C2 (ru) | 2004-02-10 |
| SK18872000A3 (sk) | 2001-07-10 |
| US7157092B1 (en) | 2007-01-02 |
| HUP0102475A3 (en) | 2001-12-28 |
| JP2002519338A (ja) | 2002-07-02 |
| WO2000000462A1 (fr) | 2000-01-06 |
| EE200000791A (et) | 2002-02-15 |
| AU4284899A (en) | 2000-01-17 |
| JP4699609B2 (ja) | 2011-06-15 |
| BR9911329A (pt) | 2001-10-16 |
| EE04489B1 (et) | 2005-06-15 |
| CZ20004893A3 (en) | 2001-05-16 |
| ES2284275T3 (es) | 2007-11-01 |
| DK1091928T3 (da) | 2007-07-23 |
| KR100766016B1 (ko) | 2007-10-11 |
| CZ302062B6 (cs) | 2010-09-22 |
| EP1091928A1 (fr) | 2001-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK287073B6 (sk) | N-Acyldipeptidový derivát, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje | |
| US7799762B2 (en) | Acyl pseudodipeptides which carry a functionalised auxialiary arm | |
| FI120689B (fi) | Immunologinen adjuvanttiyhdiste | |
| EP2039361A2 (en) | Use of immunomodulatory compounds | |
| JP2003518086A5 (zh) | ||
| AU2007222135B2 (en) | Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines | |
| US20130022628A1 (en) | Acyl pseudopeptides which carry a functionalized auxiliary arm | |
| KR100898844B1 (ko) | 작용기화된 보조 아암을 가진 아실 슈도디펩티드 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20130623 |